CureVac (NASDAQ:CVAC) | WebDisclosure

Basculer en Français

8721	Companies
153109	Keywords
88688	Articles
82306	Press releases

Home
Companies
CureVac

BRIEF

published on 05/20/2025 at 13:05, 28 days 7 hours ago

CureVac publie ses résultats financiers et ses développements commerciaux pour le premier trimestre 2025

Résultats Financiers Brevets Revenu Pipeline En Oncologie Développements En R&D
BRIEF

published on 05/20/2025 at 13:05, 28 days 7 hours ago

CureVac Reports Q1 2025 Financials and Business Developments

Financial Results Revenue Patents Oncology Pipeline R&D Developments
PRESS RELEASE

published on 05/20/2025 at 13:00, 28 days 7 hours ago

CureVac Announces Financial Results for the First Quarter of 2025 and Provides Business Updates
CureVac announces financial results for Q1 2025 and updates on lung cancer and glioblastoma trials, urinary tract infection vaccine, and mRNA patents. Cash position strong at €438.3 million

Financial Results Oncology Pipeline CureVac Q1 2025 MRNA Patents
BRIEF

published on 05/15/2025 at 22:15, 1 month 1 day ago

CureVac obtient une décision favorable en matière de brevets contre BioNTech

BioNTech CureVac Technologie De L'ARNm Office Européen Des Brevets Litiges En Matière De Brevets
BRIEF

published on 05/15/2025 at 22:15, 1 month 1 day ago

CureVac Gains Favorable Patent Decision Against BioNTech

BioNTech MRNA Technology CureVac Patent Litigation European Patent Office
PRESS RELEASE

published on 05/15/2025 at 22:10, 1 month 1 day ago

CureVac Receives Additional Positive Validity Decision from European Patent Office in Ongoing Litigation Against BioNTech SE
CureVac receives positive validity decision on European patent against BioNTech SE in ongoing litigation, marking second EPO ruling in favor of CureVac

Patent BioNTech SE Litigation CureVac European Patent Office
BRIEF

published on 04/10/2025 at 13:17, 2 months 7 days ago

CureVac's 2024 Financial Results and Strategic Developments

Financial Results MRNA Technology Patent Litigation GSK Collaboration Oncology Programs
BRIEF

published on 04/10/2025 at 13:17, 2 months 7 days ago

Résultats financiers et développements stratégiques de CureVac pour 2024

Résultats Financiers Technologie De L'ARNm Collaboration GSK Litiges En Matière De Brevets Programmes D'oncologie
PRESS RELEASE

published on 04/10/2025 at 13:12, 2 months 7 days ago

CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2024 and Provides Business Update
CureVac announces financial results for the fourth quarter and full-year 2024 and provides a business update, including milestone achievements, financial discipline, and litigation updates

Financial Results Business Update Intellectual Property CureVac Precision Immunotherapy
BRIEF

published on 04/08/2025 at 13:05, 2 months 9 days ago

CureVac Announces Financial Results and Business Update for 2024

Financial Results Conference Call Business Update MRNA Technology CureVac

Accesswire

Published on 06/17/2025 at 20:00, 27 minutes ago

PPX Mining Announces Second Debenture Conversion By RIVI
Published on 06/17/2025 at 17:25, 3 hours 2 minutes ago

EON Resources Inc. Announcement
Published on 06/17/2025 at 15:00, 5 hours 27 minutes ago

Jaguar Health Presenting June 18 at Emerging Growth Conference to Provide Updates on Near-Term Catalysts
Published on 06/17/2025 at 15:00, 5 hours 27 minutes ago

Brenmiller Energy Ltd. Announces Expected Implementation of 5-for-1 Reverse Share Split
Published on 06/17/2025 at 14:30, 5 hours 57 minutes ago

Klondike Gold Completes Phase 1 Exploration Program

View all ACCESSWIRE

EQS Group

Published on 06/17/2025 at 20:00, 27 minutes ago

Walor North America Inc. has acquired TSM Corporation from HCI Equity Partners and minority shareholders
Published on 06/17/2025 at 19:49, 37 minutes ago

EQS-Adhoc: Gerresheimer AG reacts to media reports
Published on 06/17/2025 at 19:22, 1 hour 4 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/17/2025 at 19:15, 1 hour 11 minutes ago

Scaling, growth and increased profitability in the first quarter of 2025
Published on 06/17/2025 at 18:32, 1 hour 55 minutes ago

EQS-Adhoc: First Sensor AG: Adjustment of guidance for financial year 2025

Les Echos

Published on 06/17/2025 at 18:40, 1 hour 46 minutes ago

RAPPORT ANNUEL FINANCIER EXERCICE 2024
Published on 06/17/2025 at 17:45, 2 hours 41 minutes ago

EURAZEO COMPLETES MAJORITY INVESTMENT IN MAPAL
Published on 06/17/2025 at 17:45, 2 hours 41 minutes ago

EURAZEO FINALISE SON INVESTISSEMENT MAJORITAIRE DANS MAPAL
Published on 06/17/2025 at 17:45, 2 hours 42 minutes ago

Succès d’une émission obligataire en Sustainability-Linked Bond de 650 millions d’euros à 7,9 ans
Published on 06/17/2025 at 17:45, 2 hours 42 minutes ago

Success of a 650 million euros 7.9-year Sustainability-Linked Bond

View all LES ECHOS COMFI WIRE